JG
VIR icon

Jain Global’s Vir Biotechnology VIR Stock Holding History

Jain Global’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-72,991
Closed -$440K – 1680
2025
Q4 		$440K Buy
72,991
+54,615
+297% +$325K ﹤0.01% 860
2025
Q3 		$105K Buy
+18,376
New +$94K ﹤0.01% 942

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Jain Global's VIR Position: Q1 2026 in Review

Jain Global sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 72,991 shares — an estimated $440K sold.

Jain Global first reported a position in VIR in Q3 2025 and held it in 2 quarters. The position peaked at $440K in Q4 2025. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Jain Global reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 72,991 Vir Biotechnology shares in Q1 2026, an estimated $440K.
  • Jain Global first reported a position in Vir Biotechnology in Q3 2025 and held it in 2 quarters.
  • Jain Global's Vir Biotechnology position peaked at $440K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.